Literature DB >> 17410469

Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

J J Moyle1, A M Fox, M Arthur, M Bynevelt, J R Burnett.   

Abstract

Phenylketonuria (PKU; OMIM 261600) is an autosomal recessive inborn error of phenylanaline metabolism. PKU is characterized by deficient or defective phenylalanine hydroxylase activity and persistantly increased levels of the essential amino acid phenylalanine in the circulation. The present article examines current understanding of the etiology of PKU, along with a meta-analysis examining neuropsychological and intellectual presentations in continuously treated adolescents and adults. Patients with PKU differed significantly from controls on Full-Scale IQ, processing speed, attention, inhibition, and motor control. Future research utilizing an integrative approach and detailed analysis of specific cognitive domains will assist both the scientist and clinician, and ultimately the patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410469     DOI: 10.1007/s11065-007-9021-2

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  68 in total

1.  The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis.

Authors:  A Miyake; N P Friedman; M J Emerson; A H Witzki; A Howerter; T D Wager
Journal:  Cogn Psychol       Date:  2000-08       Impact factor: 3.468

2.  Phenylketonuria in adulthood: a collaborative study.

Authors:  R Koch; B Burton; G Hoganson; R Peterson; W Rhead; B Rouse; R Scott; J Wolff; A M Stern; F Guttler; M Nelson; F de la Cruz; J Coldwell; R Erbe; M T Geraghty; C Shear; J Thomas; C Azen
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

3.  Evidence for central nervous system glial cell plasticity in phenylketonuria.

Authors:  C A Dyer; A Kendler; T Philibotte; P Gardiner; J Cruz; H L Levy
Journal:  J Neuropathol Exp Neurol       Date:  1996-07       Impact factor: 3.685

4.  Sustained and selective attention as measures of genetic liability to schizophrenia.

Authors:  L A Jones; A G Cardno; R D Sanders; M J Owen; J Williams
Journal:  Schizophr Res       Date:  2001-03-30       Impact factor: 4.939

5.  Event-related potentials elicited during a visual Go-Nogo task in adults with phenylketonuria.

Authors:  J J Moyle; A M Fox; M Bynevelt; M Arthur; J R Burnett
Journal:  Clin Neurophysiol       Date:  2006-08-21       Impact factor: 3.708

6.  Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.

Authors:  J Weglage; K Ullrich; M Pietsch; B Fünders; F Güttler; E Harms
Journal:  Pediatr Res       Date:  1997-09       Impact factor: 3.756

Review 7.  Remyelination in multiple sclerosis.

Authors:  Wolfgang Brück; Tanja Kuhlmann; Christine Stadelmann
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

Review 8.  Neuropsychological aspects of multiple sclerosis.

Authors:  J C Brassington; N V Marsh
Journal:  Neuropsychol Rev       Date:  1998-06       Impact factor: 7.444

9.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

10.  Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria.

Authors:  S C J Huijbregts; L M J De Sonneville; F J Van Spronsen; I E Berends; R Licht; P H Verkerk; J A Sergeant
Journal:  Neuropsychology       Date:  2003-07       Impact factor: 3.295

View more
  46 in total

1.  A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study.

Authors:  S H L Yi; J A Kable; M L Evatt; R H Singh
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-10-14       Impact factor: 4.006

2.  Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.

Authors:  Benedikt Sundermann; Bettina Pfleiderer; Harald E Möller; Wolfram Schwindt; Josef Weglage; Jöran Lepsien; Reinhold Feldmann
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

3.  Unusual presentation of two Chinese phenylketonuria sisters who were misdiagnosed for years.

Authors:  Xiaomei Liu; Hui Guo; Mahesh Dahal; Bingyin Shi
Journal:  BMJ Case Rep       Date:  2013-09-24

4.  Connecting mutant phenylalanine hydroxylase with phenylketonuria.

Authors:  Shaomin Yan; Guang Wu
Journal:  J Clin Monit Comput       Date:  2008-09-05       Impact factor: 2.502

5.  Successful Live Birth following Preimplantation Genetic Diagnosis for Phenylketonuria in Day 3 Embryos by Specific Mutation Analysis and Elective Single Embryo Transfer.

Authors:  Stuart Lavery; Dima Abdo; Mara Kotrotsou; Geoff Trew; Michalis Konstantinidis; Dagan Wells
Journal:  JIMD Rep       Date:  2012-03-31

6.  The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.

Authors:  A Bartus; F Palasti; E Juhasz; E Kiss; E Simonova; Cs Sumanszki; P Reismann
Journal:  Metab Brain Dis       Date:  2018-06-12       Impact factor: 3.584

7.  Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.

Authors:  Yihan Sun; Jae Hyun Kim; Kiran Vangipuram; Daniel F Hayes; Ellen M L Smith; Larisa Yeomans; N Lynn Henry; Kathleen A Stringer; Daniel L Hertz
Journal:  Breast Cancer Res Treat       Date:  2018-06-26       Impact factor: 4.872

8.  Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.

Authors:  Filippo Manti; Francesca Nardecchia; Sabrina Paci; Flavia Chiarotti; Claudia Carducci; Carla Carducci; Silvia Dalmazzone; Graziella Cefalo; Elisabetta Salvatici; Giuseppe Banderali; Vincenzo Leuzzi
Journal:  J Inherit Metab Dis       Date:  2017-08-23       Impact factor: 4.982

Review 9.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

10.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.